Control of T-Cell–Mediated Immune Response by HLA Class I in Human Pancreatic Carcinoma
Author:
Affiliation:
1. 2Surgery and
2. 1Unit for Documentation and Statistics, Department of Surgery, and Departments of
3. 3Pathology, University of Heidelberg, Heidelberg, Germany and
4. 4Department of Veterinary Surgery, University of Leipzig, Germany
Abstract
Publisher
American Association for Cancer Research (AACR)
Subject
Cancer Research,Oncology
Link
https://aacrjournals.org/clincancerres/article-pdf/11/2/498/1961830/498-504.pdf
Reference36 articles.
1. Rammensee H-G, Falk K, Rotzschke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993;11:213–44.
2. Daniels MA, Jameson SC. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers. J Exp Med 2000;191:335–46.
3. Grandis JR, Falkner DM, Melhem MF, et al. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences. Clin Cancer Res 2000;6:2794–802.
4. Algarra I, Cabrera T, Garrido F. The HLA crossroad in tumor immunology. Hum Immunol 2000;61:65–73.
5. Koopman LA, Corver WE, van der Slik AR, Giphart MJ, Fleuren GJ. Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer. J Exp Med 2000;191:961–76.
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression;Cellular Oncology;2024-02-05
2. Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial;Nature Medicine;2024-01-09
3. The role of HLA genetic variants in COVID‐19 susceptibility, severity, and mortality: A global review;Journal of Clinical Laboratory Analysis;2024-01
4. Cancer—avoiding immune detection;Clinical Immuno-Oncology;2024
5. Autophagy as a critical driver of metabolic adaptation, therapeutic resistance, and immune evasion of cancer;Current Opinion in Biotechnology;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3